Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxinning tablets in coronary heart disease with heart failure
ChiCTR2500095860Phase 4Recruiting
- Sponsor
- Dongyang People's Hospital
- Start
- Jan 2025
- Countries
- 1
01
Overview
Phase 4 trial of Guanxinning in coronary arteriosclerosis and chronic heart failure (CHF) (2 arms), sponsored by Dongyang People's Hospital. Primary endpoints: Echocardiography, N-terminal B-type pro-natriuretic peptide (NT-proBNP) and 3 more. Started Jan 2025; status: recruiting.
02
Drugs
Guanxinning
03
Conditions
coronary arteriosclerosischronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR2500095860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095860.